Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 4

Sponsor Class

OTHER 7NETWORK 4INDUSTRY 2OTHER_GOV 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Breast Neoplasms 5Recurrence 4Lung Neoplasms 4Hodgkin Disease 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 2Rhabdomyosarcoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Adenocarcinoma of Lung 2Sarcoma 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Prostatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasm Metastasis 1Melanoma 1Familial ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Vinorelbine 4Dexamethasone 4Filgrastim 3Vincristine 2Peripheral Blood Stem Cell Transplantation 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Fenretinide 2Etoposide 2Cytarabine 2Carmustine 2Bortezomib 2zanubrutinib 1relatlimab 1pomalidomide 1pegaspargase 1palbociclib 1liposomal amphotericin B 1ixazomib 1irinotecan sucrosofate 1interferon gamma-1b 1interferon gamma, Cys(-3), Tyr(-2), Cys(-1)- 1imetelstat 1etoposide phosphate 1elotuzumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1carfilzomib 1auricularum 1aldesleukin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Recurrence × Vinorelbine × Clear all
NCT03443128 2025-02-13

Vinorelbine for Recurrent ALCL-2017

Children's Cancer Group, China

Phase 2 Completed
20 enrolled
Lymphoid

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT03397953 2022-07-26

Vinorelbine for Recurrent ACLC

Children's Cancer Group, China

Phase 2 Completed
20 enrolled
Lymphoid

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT00006760 2013-07-26

Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma

Children's Oncology Group

Phase 2 Completed
66 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

NCT00070304 2013-07-26

Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

Children's Oncology Group

Phase 2 Completed
33 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡